Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/7CA stock hub

FRA/7CA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/7CAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.1B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/7CA

In the news

Latest news · FRA/7CA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E40.6

P25 n/aP50 n/aP75 n/a

Trailing P/E45.1

P25 n/aP50 n/aP75 n/a

ROE19.5

P25 n/aP50 n/aP75 n/a

ROIC105.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/7CA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

203

Groups with data

Currency

SEK

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	DE
Employees	285
Employees Change	29%
Employees Change Percent	11.33
Enterprise value	EUR 2.7B
Exchange	Frankfurt Stock Exchange
Financial currency	SEK
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 3.1B
Price	EUR 50.85
Price currency	EUR
Rev Per Employee	763,968.41x
Sic	2834
Symbol	fra/7CA
Website	https://www.camurus.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.22%
EV Earnings	40.2x
EV/EBIT	33.51x
EV/EBITDA	32.65x
EV/FCF	40.43x
EV/Sales	13.09x
FCF yield	2.2%
Forward P/E	40.61x
P/B ratio	7.83x
P/E ratio	45.1x
P/S ratio	14.65x
PE Ratio3 Y	75.53x
PE Ratio5 Y	118.64x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	39.07%
EBITDA Margin	39.33%
FCF margin	32.29%
Gross margin	93.11%
Gross Profit	EUR 194.9M
Gross Profit Growth	21.36%
Gross Profit Growth Q	-17.65%
Gross Profit Growth3 Y	35.22%
Gross Profit Growth5 Y	47.64%
Net Income	EUR 68M
Net Income Growth	71.7%
Net Income Growth Q	-31.37%
Net Income Growth3 Y	136.58%
Pretax Margin	41.19%
Profit Margin	32.47%
Profit Per Employee	EUR 248,060
ROA	13.02
Roa5y	8.23
ROCE	20.24
ROE	19.55
Roe5y	13.5
ROIC	105.4
Roic5y	63.11

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	23.05%
Cagr1y	-16.72%
Cagr3y	32.61%
Cagr5y	20.05%
EPS Growth	70.28
EPS Growth Q	-32.01
EPS Growth3 Y	132.9
FCF Growth	102.96%
FCF Growth Q	149%
FCF Growth3 Y	94.57%
OCF Growth	124.05%
OCF Growth Q	147.39%
OCF Growth3 Y	104.8%
Revenue Growth	21.3x
Revenue Growth Q	-16.03x
Revenue Growth3 Y	33.3x
Revenue Growth5 Y	46.47x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.53
Assets	EUR 438M
Cash	EUR 344.3M
Current Assets	EUR 408.4M
Current Liabilities	EUR 33.8M
Debt	EUR 9.8M
Debt EBITDA	EUR 0.12
Debt Equity	EUR 0.03
Debt FCF	EUR 0.14
Equity	EUR 391.4M
Interest Coverage	156.7
Liabilities	EUR 46.6M
Long Term Assets	EUR 29.6M
Long Term Liabilities	EUR 12.8M
Net Cash	EUR 334.5M
Net Cash By Market Cap	EUR 10.91
Net Cash Growth	27.66%
Net Debt EBITDA	EUR -4.06
Net Debt Equity	EUR -0.85
Net Debt FCF	EUR -4.95
Tangible Book Value	EUR 391.4M
Tangible Book Value Per Share	EUR 6.59

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	12.09
Inventory Turnover	1.24
Net Working Capital	EUR 33.7M
Quick ratio	11.67
Working Capital	EUR 376.2M
Working Capital Turnover	EUR 0.06

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.85%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	695.83%
1Y total return	-16.71%
200-day SMA	56.22
3Y total return	133.26%
50-day SMA	46.32
50-day SMA vs 200-day SMA	50under200
5Y total return	149.27%
All Time High	67.8
All Time High Change	-25%
All Time High Date	2025-09-11
All Time Low	5.46
All Time Low Change	831.32%
All Time Low Date	2020-03-19
ATR	1.08
Ch YTD	-11.1
High	50.85
High52	67.8
High52 Date	2025-09-11
High52ch	-25%
Low	50.85
Low52	40.6
Low52 Date	2026-03-25
Low52ch	25.25%
Ma50ch	9.78%
Price vs 200-day SMA	-9.55%
RSI	57.2
RSI Monthly	50.77
RSI Weekly	47.41
Sharpe ratio	-0.16x
Sortino ratio	-0.12
Total Return	-0.85%
Tr YTD	-11.1
Tr1m	14.58%
Tr1w	2.4%
Tr3m	-19.6%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 81.8M
Operating Income Growth	90.92
Operating Income Growth Q	-22.75
Operating Income Growth3 Y	131.6
Operating margin	39.07

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	36,801,735%
Net Borrowing	-1,666,719.1
Shares Insiders	3.24%
Shares Institutions	35.6%
Shares Qo Q	0%
Shares Yo Y	0.85%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 67.8M
Average Volume	20x
Bv Per Share	6.59
CAPEX	EUR -12.7M
Ch10y	628.6
Ch1m	14.58
Ch1w	2.4
Ch1y	-16.71
Ch3m	-19.6
Ch3y	133.3
Ch5y	149.3
Ch6m	2.19
Change	-2.4%
Change From Open	0
Close	52.1
Days Gap	-2.4
Depreciation Amortization	530,545.6
Earnings Date	2026-04-29
EBIT	EUR 81.8M
EBITDA	EUR 82.3M
EPS	EUR 1.13
F Score	6
FCF	EUR 67.6M
FCF EV Yield	2.47x
Financing CF	14,627,091
Fiscal Year End	December
Founded	1,991
Graham Number	12.83233
Graham Upside	-74.76
Income Tax	EUR 18.3M
Investing CF	-12,800,010
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2025-12-31
Lynch Fair Value	EUR 28.18
Lynch Upside	-44.57
Ma150	54.15
Ma150ch	-6.09%
Ma20	50.03
Ma20ch	1.64%
Net CF	80,692,436
Next Earnings Date	2026-05-12
Open	50.85
P FCF Ratio	45.36
P OCF Ratio	38.17
Ppne	25,656,194.1
Price Date	2026-05-08
Price EBITDA	EUR 37.24
Ptbv Ratio	7.83
Relative Volume	1x
Revenue	209,327,343x
SBC By Revenue	-0.11x
Share Based Comp	-239,139
Tax By Revenue	8.72x
Tax Rate	21.17%
Tr6m	2.19%
Z Score	46.37

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/7CA pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/7CA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/7CA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+35.6%

Share of float held by funds and institutions

Insider ownership

+3.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.9%

Negative means the company is buying back shares.

Technical

FRA/7CA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.2

Neutral momentum band

Price vs 200-day MA

-9.5%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.16

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/7CA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/7CA stock rating?

fra/7CA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/7CA analysis?

The full report lives at /stocks/fra/7CA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/7CA?

The latest report frames fra/7CA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/7CA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.